20 Years ECA Academy

From 6-7 June 2019 in Heidelberg, Germany

Join us and celebrate the 20 years anniversary of ECA in Heidelberg at the 8th European GMP Conference
- Meet speakers from US FDA, EU GMP Inspectorates and Pharmaceutical Industry to hear the latest GMP Trends
- Receive the latest ECA Guidance Documents at no costs!

Find out more

Acknowledged GMP/GDP Certification

Highly qualified personnel is crucial in the pharmaceutical industry. The ECA Certification scheme with 14 continuous education programmes trains you adequately.

GMP/GDP Training Matrix

Are you looking for certain GMP/GDP Training Courses? The GMP/GDP Matrix will help you find your training course.

Find out more

ECA – Your GMP/GDP Information Source

With news, trainings and conferences, a comprehensive guidelines database, publications and more the ECA is the leading European training and information services provider in the GMP and GDP environment.

Latest GMP News

Apr 17

GMP for Sterile Containers ...

Following the Q&As on what data is required for sterilization processes of primary packaging materials published in 2016, the EMA recently released the new Guideline on the sterilization of the medicinal product, active substance, excipient and primary container.

More GMP for Sterile Containers

Apr 17

Warning Letter for US Contract Manufacturer: Cleaning, Contamination Control and ...

In March, the American authority FDA issued a Warning Letter to a US pharmaceutical manufacturer due to numerous violations of GMP. Among other things, inadequate cleaning of the equipment, errors in the stability studies as well as in contamination control were found.

More Warning Letter for US Contract Manufacturer: Cleaning, Contamination Control and Stability Studies criticised

Apr 17

Critical Process Parameters and Process Validation ...

Regulations require that the critical process variables should be included in validation. This has been recently confirmed again by the FDA in a Warning Letter.

More Critical Process Parameters and Process Validation

Apr 10

FDA establishes a working group on cannabis and cannabis-derived products ...

There is currently a growing interest in the development of therapies derived from cannabis and its components.The FDA recently announced to form an internal agency working group to explore potential pathways for dietary supplements and/or conventional foods containing CBD.

More FDA establishes a working group on cannabis and cannabis-derived products

Apr 10